Podcasts about therapeutic guidelines

Dhineli Perera chats with Allen Cheng, director of Infectious Diseases at Monash Health and member of the Antibiotic Expert Group, about some of the updates in the latest version of Therapeutic Guidelines: Antibiotic. Allen talks about changes to severity assessment and treatment for community-acquired pneumonia, updated antimicrobial dosing advice, a new tiered approach for managing patients with sepsis and much more.

Justin Coleman sits down with Lee Fong to discuss the changes to the latest version of Therapeutic Guidelines: Dermatology. Lee talks about misconceptions around the use of topical corticosteroids, tailoring treatments to the subtype of acne, and management tips for scabies, sweating disorders, psoriasis and much more.

SGLT2 inhibitors and GLP-1 receptor agonists now have well-established cardiovascular and renal benefits. What does this mean for their role in the management of type 2 diabetes? Justin Coleman chats with endocrinologist and clinical pharmacologist, Tilenka Thynne, about this and other updates to Therapeutic Guidelines Diabetes.

Justin Coleman chats with GP and addiction specialist, Dr Hester Wilson, about Therapeutic Guidelines' first ever Addiction guidelines.

Dr Hung The Nguyen was the 2021 RACGP GP of the year.  He is a General Practitioner in the Aboriginal Community Controlled Bunurong Health Service.   Hung was the inaugural Censor for the RACGP National Aboriginal and Torres Strait Islander Health Faculty and sits on multiple boards including as Chair of the VACCHO GP Expert Advisory Group, a Councillor on the AMA Victoria Council, Therapeutic Guidelines, Health Education Australia Limited, and is the President of the Australasian Society of Lifestyle Medicine. Interested in studying lifestyle medicine, health coaching and new models of care in health and wellbeing?  Check out the JCU postgraduate courses: Grad Cert, Grad Diploma, and Master.  If you find this podcast valuable then subscribing, sharing, rating it 5 stars and leaving a review is appreciated. If you would like to send in your thoughts, insights, opinions, provide feedback or request a topic, please contact me via thegpshow.com  Thank you for listening and your support.

Justin Coleman chats to gastroenterologist Chris Rayner about gastrointestinal disorders – from the top to the bottom.

Host: Mario R. Nacinovich, Jr., MSc Guest: Richard Kojan, MD As the fight against Ebola continues, can a new biosecure emergency care unit (CUBE) and therapeutic guidelines from the World Health Organization (WHO) help combat this disease? Mario Nacinovich joins study Dr. Richard Kojan, President of the Alliance for International Medical Action, to discuss these new guidelines.

Justin Coleman chats to infectious diseases physician Emily Tucker about one of the more common presentations in primary care – sore throat.

Justin Coleman chats to Charmaine Tate about how to prevent, prepare for and manage injuries incurred from being exposed to the great outdoors.

What's the latest management advice for anxiety, insomnia, dementia, suicide risk and personality disorders? Justin Coleman chats to GP Nick Carr who is one of the authors of the 8th edition of the Psychotropic guidelines.

Justin Coleman chats to Nick Lennox, one of the authors behind the latest update to the Developmental Disability guidelines, which involves a strong focus on what to look out for as a GP.

Justin Coleman chats to hepatologist Alex Thompson about livers and what can go wrong with them, including hepatitis B, C and non-alcoholic fatty liver disease.

Dr Cathy Franklin is a psychiatrist and Senior Research Fellow who specialises in intellectual and developmental disability.  Cathy is the inaugural Director of the Mater Intellectual Disability and Autism Service (MIDAS) that works to improve the health and mental health of adults with intellectual or developmental disability (including autism). Cathy has also recently become Director the Queensland Centre for Intellectual and Developmental Disability, and is Vice-President of the Australian Association of Developmental Disability Medicine (AADDM). In 2020 she was awarded the Mater Research Sister Regis Dunne award for Outstanding Contribution to research relative to opportunity. Today we are discussing the updated Developmental Disability management guidelines from  Therapeutic Guidelines from https://www.tg.org.au/ . If you find this podcast valuable, rating it 5 stars and leaving a review on your podcast app is appreciated. If you would like to provide feedback or request a topic, please Contact Us. Thank you for listening.

Managing pain involves more than just analgesia, as reflected in the Therapeutic Guidelines' extensive revision of this topic. Justin Coleman chats to pain specialist Chris Hayes about the more holistic, multidimensional approach to pain management.

Justin Coleman chats with Medical Director of Family Planning NSW Deborah Bateson about the latest updates on sexual and reproductive health published by Therapeutic Guidelines. Their conversation covers the completely revised topic of contraception, endometriosis, infertility, menopause, medical abortion and, something for the blokes, testosterone deficiency.

Kristin spoke with Dr Eli Dabscheck and Dr Johnson George about all things Chronic Obstructive Pulmonary Disease (COPD) including: Risk factors  Management Exacerbations of COPD and the issues around the appropriate use of antimicrobials in this situation  The Therapeutic Guidelines and COPD-X Guideline recommendations Asthma and COPD overlap  The benefits of medication reviews and COPD action plans 

Justin Coleman chats with fellow GP Malcolm Clark about the extensively revised Respiratory guidelines published by Therapeutic Guidelines.

Latest updates on toxicology and toxinology from Therapeutic Guidelines

Latest updates on oral and dental conditions from Therapeutic Guidelines

What are the latest antibiotic updates from Therapeutic Guidelines?

Latest updates on bone and metabolism from Therapeutic Guidelines.

Dr Greg Rowles is a General Practitioner from Riddells Creek in rural Victoria, and a member of an Expert Group which developed and reviewed Version 16 of the Antibiotic Guidelines. Today we discuss: Antibiotic stewardship and practical GP considerations in antibiotic prescribing including shared decision making, penicillin hypersensitivity, paediatric recommendations etc Ear nose throat: Acute otitis media and tonsillitis update Respiratory: Community-acquired pneumonia update Genitourinary: UTI and STI update GIT: Diverticulitis and parasite update Dermatology: Cellulitis, bite wounds, diabetic foot infection And tangential questions in-between! Conflict of interest: Dr Rowles is obviously associated with the Therapeutic Guidelines.  However, there are no conflicts of interest for myself/The GP Show podcast.   I did NOT receive any financial payment for this episode.   Enjoy friends.

Latest updates to Therapeutic Guidelines’ ulcer and wound management.

  This episode we celebrate the release of the new Therapeutic Guidelines - Antibiotic! Jane and Kristin are joined by Senior Editor Jess Gibney and Dr Emily Tucker, ID Physician from Flinders Medical Centre to discuss what’s new and what’s changed. Things we learnt include: How to say Happy Easter in Greek How Therapeutics Guidelines put its expert groups together The process of updating guidelines Why TG is no longer being published in hard copy Changes to surgical prophylaxis recommendations The new inclusion of intravenous Amoxicillin/Clavulanate as a treatment option, and the behind the scenes discussion around the use of this agent, including dosing controversies New advice for Ceftriaxone dosage The choice to expand advice around “watching and waiting” and when NOT to use antibiotics A new approach to the classification of community acquired pneumonia Significant changes to advice around antibiotic allergies (side chains!) Some challenges in updating the paediatric section of the Guidelines Visit the Therapeutic Guidelines at http://www.tg.org.au

Latest updates to Therapeutic Guidelines for diabetes.

Jane caught up with two members of the writing group for the recently updated Therapeutic Guidelines: Cardiovascular. Confusingly, they are also called Jane and Dan! Jane O'Connor is an Editor at Therapeutic Guidelines and Dr Daniel Scherer is a Cardiologist and PhD Candidate at the South Australian Health and Medical Research Institute.

Background: The introduction of new invasive therapies for acute myocardial infarction and new medication schemes for secondary prevention is thought to increase life expectancy in 28-day survivors of a first myocardial infarction. The present study examined mortality and re-infarction rate of those patients in the light of changed therapeutic guidelines. Methods: Cases of 25 to 74 year old 28-day survivors of a first definite AMI based on MONICA criteria were identified in the Coronary Event Registry in Augsburg, Southern Germany, who had their index event between the 1st of January 1995 and the 31st of December 2003. Mortality and re-infarction rates were calculated for 1 year, 3 years and total follow-up. Cox models were built to compare the rates of persons, who suffered the index event between 1995 and 1999 (Study period 1) with those who had their first AMI between 2000 and 2003 (Study period 2). Results: Crude mortality was higher in Study period 1 than in Study period 2 and higher for women than for men. Re-infarction rates remained stable for men during both study periods, but women from Study period 1 had a much higher re-infarction rate than women in Study period 2. The hazard ratios showed no significant differences for mortality and re-infarction in men. Hazard ratios of re-infarction in women were significantly reduced, but have to be treated with caution as the number of re-infarctions during Study period 2 was very small. Mortality hazard ratios in women were also not significant. Conclusions: When comparing the time periods before and after the introduction of new therapeutic guidelines, an effect on mortality or re-infarction rate cannot be established. Several reasons are probably responsible for this finding. The population of patients has changed with respect to their risk factors and new diagnostic criteria may have also contributed. Further studies are needed to illuminate these questions.